Pathway Financial Advisers’s Amgen AMGN Stock Holding History

Pathway Financial Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.48M	Sell	9,887 -5,382	-35%	-$1.92M	0.98%	36
2025 Q4	$5M	Sell	15,269 -116	-0.8%	-$36.8K	1.45%	17
2025 Q3	$4.3M	Buy	15,385 +694	+5%	+$201K	1.26%	24
2025 Q2	$4.1M	Buy	14,691 +197	+1%	+$55.8K	1.33%	21
2025 Q1	$4.52M	Buy	14,494 +519	+4%	+$153K	1.55%	17
2024 Q4	$3.64M	Buy	13,975 +132	+1%	+$39.2K	1.22%	25
2024 Q3	$4.46M	Buy	13,843 +419	+3%	+$137K	2.02%	12
2024 Q2	$4.16M	Buy	13,424 +257	+2%	+$75.5K	1.49%	16
2024 Q1	$3.74M	Sell	13,167 -262	-2%	-$76.7K	1.35%	22
2023 Q4	$3.87M	Sell	13,429 -34	-0.3%	-$9.26K	1.47%	15
2023 Q3	$3.62M	Buy	+13,463	New	+$3.36M	1.49%	15
2023 Q1	$2.93M	Sell	12,140 -22	-0.2%	-$5.4K	1.18%	25
2022 Q4	$3.19M	Buy	+12,162	New	+$3.26M	1.29%	20

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Pathway Financial Advisers's AMGN Position: Q1 2026 in Review

Pathway Financial Advisers reduced its Amgen (AMGN) stake by 35% in Q1 2026, selling an estimated $1.92M and leaving 9,887 shares worth $3.48M. The position accounts for 0.98% of the portfolio, ranked #36.

Pathway Financial Advisers first reported a position in AMGN in Q4 2022 and has held it in 13 quarters since. The position peaked at $5M in Q4 2025. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Pathway Financial Advisers held 9,887 shares of Amgen worth $3.48M as of Q1 2026.
Pathway Financial Advisers sold 5,382 Amgen shares in Q1 2026, an estimated $1.92M.
Amgen made up 0.98% of Pathway Financial Advisers's portfolio in Q1 2026, its #36 holding.
Pathway Financial Advisers first reported a position in Amgen in Q4 2022 and has held it in 13 quarters since.
Pathway Financial Advisers's Amgen position peaked at $5M in Q4 2025.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Pathway Financial Advisers's 13F filing for Q1 2026, filed 23 Apr 2026.